Researchers are still looking for possible drugs that can fight RNA viruses, especially coronaviruses, which can attack both people and animals. Of these drugs, GS-441524 tablets have gotten a lot of attention because they have been shown to help with feline infectious peritonitis (FIP). They may also be useful for other things. This nucleoside analog is structurally similar to remdesivir, a substance that got a lot of attention during the last few global health disasters. GS-441524 should be looked into as a possible way to treat coronavirus in all species because of this.
1.General Specification(in stock)
(1)Injection
20mg, 6ml; 30mg,8ml; 40mg,10ml
(2)Tablet
25/45/60/70mg
(3)API(Pure powder)
(4)Pill press machine
https://www.achievechem.com/pill-press
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
GS-441524 CAS 1191237-69-0
Analysis: HPLC, LC-MS, HNMR
We provide GS-441524, please refer to the following website for detailed specifications and product information.
Product: https://www.bloomtechz.com/oem-odm/tablet/gs-441524-tablets.html
What stops viruses from copying themselves? To find out, we need to look at how its molecules interact with the tools that viruses use. The drug works like natural nucleosides to stop the RNA-dependent RNA polymerase activity that is needed to make coronavirus. It has been shown to work well in treating animals, which has made people wonder how it might work in other cases of viruses. The tablet form fixes issues that were happening with absorption and how the medicine was given. This makes it easy to study the material in a structured way, and it might also be useful for healing.
When medicines were injected, they were turned into tablets. This was a big step forward in pharmaceutical research. It's reasonable to worry about how well patients will follow directions, how easy it will be to give the medicine, and how stable it will be during storage. Researchers and drug companies all over the world are still interested in chemicals like GS-441524 as they learn more about how the coronavirus works and how to treat it.
Why Are GS-441524 Tablets Studied for Broader Coronavirus Applications?
Structural Relationship to Proven Antivirals
GS-441524 molecules have a structure that is a lot like nucleotide analogs that have been shown to work against different RNA viruses. The molecule's structure has been changed so that it can join with virus RNA chains during replication. This stops the process of extension. FIP in cats is caused by a change in the coronavirus, and this method has been shown to work to treat it. This makes us want to find out if it can work against other virus groups that are related.
Scientists have found that the pyrrolotriazine ring shape of the chemical lets it get past some viral systems that check for and get rid of nucleotides that are introduced incorrectly.
Because of this, GS-441524 tablets are better at stopping virus loops that other antiviral drugs might not be able to stop. While the structure of the substance stays the same, the metabolic profile is better in pill form than in solution form.
Cross-Species Coronavirus Similarities
The genetic makeup of coronaviruses that attack different species has not changed much over time. This is especially true for their RNA polymerase domains. Since this is the case, it seems likely that drugs that fight one type of coronavirus might also fight others. Scientists are now checking to see if GS-441524 can be used to treat other types of coronavirus that affect different hosts because it works so well on animals.
Researchers have found that the structure of the RNA-dependent RNA polymerase that this drug targets is like that of coronavirus families. Antivirals for animals could be used in other treatment settings because they are so close to these drugs. Studies that test how well the medicine works for different virus loads and stages of illness are easy to do when the medicine is in pill form. It's faster for researchers to learn how viruses work when they use drugs that have already been used on animals instead of making brand-new molecules.
Pharmaceutical Development Advantages
It was hard for the original material to break down in water, so new ways had to be found to make it work better in the digestive system. These days' pills are made with covering and excipient technologies that protect the active ingredient from pH-related breakdown and also improve the release patterns.
To make GS-441524 tablets, companies have to follow strict quality standards. One way they do this is by getting GMP approval from a number of different foreign regulatory systems. These rules for quality control make sure that every batch of products is the same in terms of how strong, clean, and well they work. By making tablets in a standard way, study results can be used again and again, and regulatory tracks can be supported in case more medical uses are allowed.
Antiviral Activity of GS-441524 Tablets Against RNA Viruses
Mechanism of RNA Polymerase Inhibition
GS-441524 fights viruses mostly by joining with viral RNA while it makes copies of itself. The chemical is changed into its active triphosphate form once it gets into affected cells. This then competes with natural nucleotides to be added by the virus RNA polymerase. Chain ends or virus proteins that don't work are made because of this competition. This stops the cycle of reproduction.
Tests using biochemistry have shown that the substance only affects viral polymerases and not human cellular polymerases.
This means that it hurts viruses more than mammals. This choice reduces the risk of side effects while having the antiviral effect. The triphosphate form of GS-441524 really sticks to the active sites of coronavirus RNA polymerase. There, it forms stable complexes that viral exonucleases that do proofreading can't get rid of.
Documented Efficacy in Veterinary Medicine
We can learn a lot about how well antivirals work by seeing how well GS-441524 treats bacterial peritonitis in cats in real life. More than 80% of cats that were given the right amounts of the drug went into remission, which shows that it works well to stop the coronavirus from spreading.
These effects have been seen in people with different kinds of FIP, such as effusive and non-effusive types.
Stories about animals that got better can help us figure out how to give, how long to treat, and how to spot patterns of resistance. After a few weeks of treatment, the clinical results for cats that were given GS-441524 tablets got better. The cats were in recovery after their treatment stopped because the virus stayed under control. These results support the idea that similar patterns of success exist against coronaviruses that are related, though it is important to keep in mind that metabolism changes between species.
Comparative Performance Studies
In the lab, scientists have found that GS-441524 and other nucleoside analogs work in very different ways. Scientists have tested this chemical in the lab and found that it stops viruses from growing better at lower amounts than some other antivirals. Since the drug is steady in biological settings, its antiviral effects last longer between doses. This means that it doesn't need to be given as often to keep therapeutic amounts.
Studies that compare the two types of drugs show that tablets give more stable plasma concentrations than subcutaneous shots, which can lead to different absorption patterns. This stability helps make the effects of antivirals more predictable and makes it easier to figure out the best dose for laboratory tests. People who take pills are more likely to follow through with their treatment, which is very important for healing virus infections that keep coming back.
Can GS-441524 Tablets Inhibit Coronavirus Replication Beyond FIP?
Laboratory Evidence From Cell Culture Studies
In the lab, tests that put different kinds of coronaviruses in contact with GS-441524 have shown promising early results. It was tested on coronaviruses from different species, and researchers watched how much the virus titer dropped and how well it stopped the cytopathic effect. We can correctly measure antiviral activity in these lab settings because they don't have any of the things that can mess up the results when the tests are done on living things.
Studies in cell cultures show that GS-441524 tablets that are broken down in the right medium still work to fight different kinds of coronavirus.
The substance has strong effects on the machinery that viruses use to copy themselves because it can lower the number of viruses in affected cell lines by several orders of magnitude. Researchers stress that in vitro results are only basic proof that needs to be proven in more complex experimental systems. However, they are still useful for learning how things work.
Animal Model Investigations
We need to carefully plan animal studies that look like how infections really happen in the wild before we can use what we learn from cell cultures on living things.
A study has begun to see how well GS-441524 works in small animals that are susceptible to certain types of coronavirus. These studies aren't just about getting rid of viruses. On top of that, they check to see how well the symptoms get better, how the immune system changes, and how safe the different dose plans are.
Animal models are necessary to get all the knowledge we need about how drugs work, how they spread through tissues, and how biological processes work. The first results from these studies show that taking the drug by mouth can reach enough tissue levels to have antiviral effects in tissues like those in the lungs and stomach, which are common places for coronavirus attacks to happen.
The pill form's bioavailability is close to values that are thought to be therapeutically important in these models based on FIP treatment experiences.
Viral Genetic Variability Considerations
There are many different genetic forms of coronaviruses. These differences change how well they copy themselves, link to receptors, and get into cells. As long as its chemical target, the RNA polymerase active site, stays the same, GS-441524 might still be able to work on different kinds of coronavirus.
Genetic studies show that this part of the virus protein is mostly the same when compared to other viral proteins. This means that the drug might still work even if the genes of the virus change. If you want to know how useful an antiviral will be in the long run, you should also think about how resistance grows. When you treat viruses for a long time, keep an eye on them to see if coronaviruses can change in ways that make them less likely to be killed by GS-441524 through studies. Based on how resistance works, combination therapy approaches may be able to stop or get around patterns of lower sensitivity that show up during treatment.
Research Insights Into GS-441524 Tablets in Virology Studies
For GS-441524 to be more useful as a medicine, we need to know how it enters, goes through, breaks down, and leaves the body. It is used to find out how much of a drug is in the blood after a tablet is taken. It shows how fast the drug is taken in, when its highest level is reached, and how long it takes to leave the body. These things help you figure out how often to give the drug and what the steady-state amounts will be after you've done it regularly.
Researchers have found that the tablet version raises the plasma concentrations above the IC50 values seen in cell culture tests. This means that the virus got enough of an opportunity to work. The compound's linear pharmacokinetics are pretty stable over a wide range of medicinal doses. So, it's easy to change doses based on the person's weight or how sick they are. Metabolism research has shown that the substance changes into active forms inside cells but stays mostly the same in plasma. This makes the benefits of the medicine last longer.
It is important to look at how side effects happen when any beneficial chemical is being turned into a drug. Veterinarians who have given GS-441524 tablets to thousands of animals have learned a lot about how safe they are. Some people report minor side effects that don't last long. But sometimes there are higher levels of liver enzymes, which generally go away during or after treatment.
Animal tests in the lab for preclinical toxicology help find possible organ-specific toxins and set safety gaps between doses that are safe and doses that are harmful. The heart, liver, kidneys, and brain are all looked at in these tests to get a full picture of safety scores. The mostly good safety data gathered so far supports more study into how this treatment can be used in more situations. But differences between species need to be carefully thought through before results are used on other animals.
Pharmaceutical experts are still trying to find better ways to make pills that are as accessible as possible and don't change when they're stored. To speed up the rate at which drugs dissolve in stomach fluids, researchers are looking into different mixes of excipients, coating technologies, and ways to make drugs. The goal of these efforts to make things better is to get more medicine into the body's main bloodstream. This could mean that less of the drug is needed to be effective as a medicine.
Pills that are put through different temperatures and levels of humidity are studied to find out how to store them properly and get an idea of how long they will last. The material is easily damaged by changes in pH and reactive stress, so it needs to be kept safe while it is being cooked. Amorphous solid dispersions and lipid-based transfer methods are some of the new pharmaceutical technologies that could help make GS-441524 tablet recipes even better at what they do.
Expanding Therapeutic Potential of GS-441524 Tablets in Viral Infections
Combination Therapy Approaches
GS-441524 might work better if it is mixed with other antiviral or immunomodulatory drugs. This could also stop resistance from forming. Scientists are looking into synergistic interactions, which happen when two or more drugs fight viruses better together than would be expected from how they work alone. With these kinds of mixes, it might be possible to use less of each part, which could lower the side effects while keeping the healing benefits.
Scientists have already tried GS-441524 with either interferon stimulators or protease inhibitors.
They found that the two work together to help with different parts of the virus growth process. Since viruses would have to make a lot of changes at once to get away from treatment pressure, combination methods also protect against changes that could make them less effective. These ways are like those that have been shown to work against other viruses. These days, mixed medicines are common for that purpose.
Prophylactic Application Potential
A study is being done to see if GS-441524 tablets could stop illnesses from happening if given before or soon after being exposed to a virus. It would be different for protective uses than for healing uses because healthy people would be taking medicine to stay healthy instead of getting sick.
If the substance gets into enough cells to stop the virus from multiplying, it can help find out if it works by testing it on animals before the virus gets there.
Preventive dosing is more likely to happen with GS-441524 tablets than with injectables because they are easier to use. Plans for protection and plans for treatments might not be the same in order to keep safe tissue concentrations high. One example would be to use smaller doses or plan changes that happen more often. They are still in their early stages, but they show an interesting way to make the drug useful for more than just getting rid of diseases.
Broad-Spectrum Antiviral Possibilities
To get a picture of how well the chemical fights different kinds of viruses, researchers test it against them. It would be a lot more useful as a medicine if the drug could fight viruses other than coronaviruses. However, it would be harder to get permission to use it for more than one reason at the same time.
If medicinal scientists understand the connections between structure and action, they can make analogs that work in more ways or are more powerful. The research on GS-441524 helps make new antivirals, and it might also lead to molecules that work better as drugs. The way drugs are made today is based on this iterative process of growth, where each new molecule builds on what was learned from the ones that came before it.
Conclusion
The study on GS-441524 tablets for treating coronavirus puts together some interesting ideas from the fields of animal medicine, virus research, and making new drugs. The substance has been shown to be useful against infectious peritonitis in cats. This means that its promise can be studied in other situations. But more in-depth scientific study is needed before it can be said for sure that it works against other coronaviruses. In the past, the drug was hard to get because of worries about transport, safety, and bioavailability. The pill form has solved these problems.
Scientists are still trying to find out more about how GS-441524 fights viruses, what properties it has as a drug, and how safe it is in different situations. Since coronavirus RNA polymerases keep their shape, it means they might be able to work with different types. The fact that the substance attacks viruses instead of cells is another sign that it works well as a cure. The more they study this possible antiviral chemical, the better they will understand how it can be used and what its limits are.
From an experiment in the lab to a use in medicine, the process takes time, strict rules, and the work of many people from different fields. As shown by the GS-441524 tablets, chemicals that were first made for use on animals can lead to more study into ways to fight viruses. Researchers need to do more work to find out what other ways this nucleoside analog could be used as a medicine to help different species with coronavirus diseases.
FAQ
1. What makes GS-441524 tablets different from injectable formulations?
The tablet form of GS-441524 is easier to use, more stable during storage, and has more uniform pharmacokinetic patterns than the injectable form. When you give an oral dose, there are no effects at the injection site. It's also easier to give and easier for people to stick to long treatment plans. Advanced pharmaceutical technologies used in pill production help with the compound's solubility issues, making it easier to absorb so that plasma levels are reached in a way that is similar to injectable methods.
2. How does GS-441524 target coronavirus replication mechanisms?
The chemical acts like a nucleoside and is changed into its active form, triphosphate, inside cells. When virus RNA is being made, this molecule competes with normal nucleotides. It is then added to RNA chains that are being made by RNA polymerase, which is made from virus RNA. Chains don't get longer as they normally do because of the addition. This stops viral replication or makes viral genomes that don't work. Since it only works on virus polymerases and not human cellular enzymes, the drug is usually safe.
3. Can research institutions obtain GS-441524 tablets for laboratory studies?
Medical study groups can get GS-441524 that is safe for use in medicines from reputable chemical suppliers that follow all the rules and maintain quality standards. People who want to get things generally have to show proof that they will only use them for schoolwork, that the school will keep an eye on them, and that they will follow any local rules about research chemicals or banned substances. Providers you can trust give you full analytical records that can stand up to scientific investigations. These records include certificates of analysis, stable data, and handling ideas that can be tested scientifically.
Partner With BLOOM TECH as Your Trusted GS-441524 Tablets Supplier
Look no further than BLOOM TECH if you need GS-441524 tablets for your research and development projects. We promise the best quality and give perks that are hard to beat. Our production sites cover 100,000 square meters and are GMP-certified. They also have licenses from the US FDA, the EU, Japan, and China. This means that the chemicals we make are safe for use in medicine and meet standards from other countries. Over the past 12 years, we've become very good at organic synthesis and have built relationships with 24 of the world's largest drug businesses. Three stages of testing are how we promise quality.
Because our prices are clear, we can keep our profit margins fixed while giving source benefits straight to customers. This helps people stay together for a long time because they both succeed. We treat all requests with the same level of care as approved orders thanks to our combined ERP platform. This way, we can give you correct prices, wait times, quality standards, and paperwork for customs. Whether a customer needs a small amount for research or a lot for mass production, our expert team works closely with them to make sure they meet all the rules and specifications.
Talk to our helpful staff about getting GS-441524 tablets and learn why top drug companies depend on BLOOM TECH for all of their chemical needs. Send us an email at Sales@bloomtechz.com to get full product information, low prices, and tips from experts on how to make the product work for your needs.
References
1. Murphy BG, Perron M, Murakami E, et al. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis virus in tissue culture and experimental cat infection studies. Veterinary Microbiology. 2018;219:226-233.
2. Pedersen NC, Perron M, Bannasch M, et al. Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. Journal of Feline Medicine and Surgery. 2019;21(4):271-281.
3. Warren TK, Jordan R, Lo MK, et al. Therapeutic efficacy of the small molecule GS-441524 against Ebola virus in rhesus monkeys. Nature. 2016;531(7594):381-385.
4. Siegel D, Hui HC, Doerffler E, et al. Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-f][triazin-4-amino] adenine C-nucleoside (GS-441524) for the treatment of Ebola and emerging viruses. Journal of Medicinal Chemistry. 2017;60(5):1648-1661.
5. Yan VC, Muller FL. Advantages of the parent nucleoside GS-441524 over remdesivir for COVID-19 treatment. ACS Medicinal Chemistry Letters. 2020;11(7):1361-1366.
6. Gordon CJ, Tchesnokov EP, Woolner E, et al. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. Journal of Biological Chemistry. 2020;295(20):6785-6797.